CP-007â Switching from intravenous to subcutaneous formulation of abatacept in a real world setting
López-Sepúlveda, R, Casanova, N MartÃnez, RodrÃguez, I Vallejo, Gomariz, M Carrasco, RodrÃguez, F Artime, Goicoechea, M Rodriguez, Hernandez, MA Calleja, Barrera, J CabezaVolume:
23
Journal:
European Journal of Hospital Pharmacy
DOI:
10.1136/ejhpharm-2016-000875.7
Date:
March, 2016
File:
PDF, 71 KB
2016